How body composition and inflammation affect outcomes in bladder cancer
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
This study is looking at how things like weight and muscle loss affect the health and treatment of people with early-stage bladder cancer, hoping to find ways to better predict outcomes and tailor treatments for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11096087 on NIH RePORTER |
What this research studies
This research investigates the relationship between body composition, inflammation, and immune responses in patients with non-muscle-invasive bladder cancer (NMIBC). It aims to understand how factors such as obesity and age-related muscle loss influence cancer prognosis and treatment response. By analyzing data from a large cohort of newly diagnosed NMIBC patients, the study will explore how these body composition characteristics may impact patient outcomes. The findings could lead to improved prognostic tools and personalized treatment strategies for bladder cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are newly diagnosed patients with non-muscle-invasive bladder cancer, particularly those who may be experiencing obesity or age-related muscle loss.
Not a fit: Patients with muscle-invasive bladder cancer or those who do not have any body composition concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prognostic assessments and tailored treatment options for bladder cancer patients based on their body composition and inflammatory status.
How similar studies have performed: Previous research has shown that body composition and inflammatory states can significantly influence cancer outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Kwan, Marilyn L — Kaiser Foundation Research Institute
- Study coordinator: Kwan, Marilyn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.